Pharma

Bangalore, India, 27th August, 2019 :To improve the ultimate health outcomes for patients and enhance their overall experience at all its facilities, Aster DM Healthcare is setting up Aster Innovation and Research Centre in Bangalore, India and GCC. Over the next three years, the Centre will aim to achieve key milestones like introduction of innovative solutions for home healthcare...

Jaipur, 26th June 2019: Netmeds.com, ‘India ki Pharmacy’ celebrates 4 successful years of providing affordable and quality healthcare solutions to its patrons with exciting offers and deals, exclusively between 26th to 29th June 2019. Customers can avail super saver deals with up to 70% on OTC Products and flat 20% discount on medicines. Our patrons can also avail an additional flat 10% cashback using Amazon Pay....

The fourth edition of India Pharmaceutical Forum, held this week in Mumbai, that brings together industry leaders, regulators, and quality heads of various companies on a single platform was conspicuous with the absence of one person, who was ubiquitous and the driving force behind the industry’s most important calendar event. Weekly wrap: Indian pharma loses its powerful voice...

Shilpa Medicare on Monday said it has received approval from the US health regulator for Gemcitabine for injection, used for treatment of various types of cancers. The approved product is a generic equivalent of reference listed drug Gemzar. The company has received US Food and Drug Administration (USFDA) approval for its...

Drug firm Strides Pharma Scienceon Wednesday said it has received the Establishment Inspection Report (EIR) from the US health regulator for its formulations facility in Bangalore. “The company’s formulations facility (KRSG Gardens) in Bangalore which was inspected by the US Food and Drug Administration (USFDA) in August 2018 and November 2018, has received the Establishment Inspection Report (EIR), thereby...

The pharmaceutical industry welcomed the government order to constitute a standing committee headed by NITI Aayog to recommend the National Pharmaceutical Pricing Authority (NPPA) in regulating prices of medicines. “This would neither favour the industry nor encourage the growth of the industry nothing of that sort, but it brings balance to decision making (on price control), and not...

NEW DELHI: The Union government on Monday formed a committee housed in its think tank NITI A ayog to recommend medicines for price control, diluting the central role of the National Pharmaceuticals Pricing Authority (NPPA) in setting drug prices. Currently, NPPA functions as an autonomous body regulating prices of medicines and health products such as stents under the National List of...

New Delhi: The government on Thursday exempted innovative medicines developed by foreign companies from price control for five years, giving Indian patients access to drugs that are currently only available abroad. These include orphan drugs that are used for treating rare medical conditions. Govt removes price cap on innovative drugs for first 5 years In amendments to the Drugs...

Zydus Cadila has received final approval from the US health regulator to market Doxycycline Hyclate delayed-release tablets, used to treat bacterial infections. Zydus Cadila gets USFDA nod for 2 drugs Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market the drug in the strengths of 75 mg, 100 mg and...

The government is planning to introduce amendments to the Drugs and Cosmetics Act, 1940 which will provide compensation to patients if they are sold a faulty medical device by a manufacturer or importer. The decision has been taken in the backdrop of the uproar caused earlier this year in India and abroad over defective hip implants from US-based...